Back to Rankings

STVN

Stevanato GroupA
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
Current thesis
Composite grade A from latest DB weights. Momentum 77.0 / Value 53.5
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -4.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
77
Value
54
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $26.22
Why
Momentum77 · Δ7d -4.2
Value54 · Δ7d +0.1
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
77
52% active weight
Current posture
7d trendImproving
Δ7d
-4.2
Δ21d
+6.9
Value
54
48% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade A. Momentum 77.0 / Value 53.5

Fundamentals (TTM)
As of 2026-06-02
Market Cap
$5.13B
Beta
0.58
Shares Out
272.9M
P/E (TTM)
34.9
P/S (TTM)
4.65
P/FCF (TTM) · Derived
-128.84
Rev YoY
+9.1%
EPS YoY
+20.1%
Gross Margin
+29.3%
Op Margin
+16.7%
Net Debt
$357.77M
Current Ratio
1.89
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology